Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: What have we learnt from the past – would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022?

Fig. 2

Kaplan Meier curves showing OS (months) according to different stages (ENETS) at first diagnosis, log-rank test, p < 0.001. Notes: Marks indicate censored cases. Median OS over all patients was 181 months (95% CI, 106 – 256 months). Abbreviations: CI, confidence interval; ENETS, European Neuroendocrine Tumor Society; OS, overall survival

Back to article page